news Novo Nordisk partners with OpenAI as AI drug discovery hopes mount By AdminApril 14, 2026Less 1 min read1 Views0 The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs. ShareTweetPinShare Previous PostAsia markets mostly higher amid hopes of a U.S.-Iran deal; China exports miss estimates Next PostEuropean markets rise on hopes that Iran peace talks can resume Leave a Reply Your email address will not be published. Required fields are marked * Save my name, email, and website in this browser for the next time I comment. You May Also Like October 2, 20250 Comments Taiwan rejects U.S. proposal for ’50-50′ chip production, says trade talks focused on tariffs April 1, 20260 Comments C.D.C. Pauses Testing for Rabies and Pox Viruses January 4, 20260 Comments U.S. prosecutors prepare case against Maduro October 30, 20250 Comments Hurricane Melissa set to trigger $150 million Jamaica catastrophe bond to help rebuild
October 2, 20250 Comments Taiwan rejects U.S. proposal for ’50-50′ chip production, says trade talks focused on tariffs
October 30, 20250 Comments Hurricane Melissa set to trigger $150 million Jamaica catastrophe bond to help rebuild